Four-year safety follow-up of the tetravalent dengue vaccine CYD-TDV

被引：6
|
作者：
Wilder-Smith, A. [1 ,2 ]
机构：
[1] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore
[2] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany
来源：
CLINICAL MICROBIOLOGY AND INFECTION | 2018年 / 24卷 / 07期
关键词：
CYD-TDV; Dengue; Safety follow-up; Tetravalent dengue vaccine; Vaccine;
D O I：
10.1016/j.cmi.2018.03.024
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：680 / 681
页数：2
相关论文
共 45 条
  • [1] SAFETY OF DENGUE VACCINE (CYD-TDV) IN ASIA: A SYSTEMATIC REVIEW
    Ismail, W. R. Wan
    Majid, M. Sh Abdul
    Li, H. Y.
    Madrim, M. F.
    Rahim, S. Sh S. Abdul
    Jeffree, M. S.
    Azhar, Z., I
    Ghazi, H. F.
    Hassan, M. R.
    INFEKTSIYA I IMMUNITET, 2021, 11 (03): : 447 - 453
  • [2] Analysis of Hospitalized and Severe Dengue Cases Over the 6 years of Follow-up of the Tetravalent Dengue Vaccine (CYD-TDV) Efficacy Trials in Asia and Latin America
    Forrat, Remi
    Dayan, Gustavo H.
    DiazGranados, Carlos A.
    Bonaparte, Matthew
    Laot, Thelma
    Rosario Capeding, Maria
    Sanchez, Leilani
    Leticia Coronel, Diana
    Reynales, Humberto
    Chansinghakul, Danaya
    Hadinegoro, Sri Rezeki S.
    Perroud, Ana Paula
    Frago, Carina
    Zambrano, Betzana
    Machabert, Tifany
    Wu, Yukun
    Luedtke, Alexander
    Price, Brenda
    Vigne, Claire
    Haney, Owen
    Savarino, Stephen J.
    Bouckenooghe, Alain
    Noriega, Fernando
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (06) : 1003 - 1012
  • [3] Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials
    Ngoc Huu Tran
    Chansinghakul, Danaya
    Chong, Chia Yin
    Low, Chian Yong
    Shek, Lynette P.
    Chan Quang Luong
    Fargo, Carina
    Wartel, T. Anh
    Sun, Sunny
    Skipetrova, Anna
    Bouckenooghe, Alain
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (10) : 2315 - 2327
  • [4] CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety
    Godoi, Isabella Piassi
    Pires Lemos, Livia Lovato
    de Araujo, Vania Eloisa
    Bonoto, Braulio Cesar
    Godman, Brian
    Guerra Junior, Augusto Afonso
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2017, 6 (02) : 165 - 180
  • [5] Clinical efficacy, Safety, and immunogenicity of a Live Attenuated Tetravalent Dengue vaccine (CYD-TDv) in Children: A Systematic Review with Meta-analysis
    Malisheni, Moffat
    Khaiboullina, Svetlana F.
    Rizvanov, Albert A.
    Takah, Noah
    Murewanhema, Grant
    Bates, Matthew
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [6] Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine
    Wilder-Smith, Annelies
    Vannice, Kirsten S.
    Hombach, Joachim
    Farrar, Jeremy
    Nolan, Terry
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (12) : 1796 - 1799
  • [7] Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 y Phase II randomized controlled trial in Singapore
    Leo, Yee Sin
    Wilder-Smith, Annelies
    Archuleta, Sophia
    Shek, Lynette P.
    Chong, Chia Yin
    Hoe Nam Leong
    Low, Chian Yong
    Oh, May-Lin Helen
    Bouckenooghe, Alain
    Wartel, T. Anh
    Crevat, Denis
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (09) : 1259 - 1271
  • [8] Long-term safety follow-up of children from a randomized-controlled phase Ⅱb proof-of-concept efficacy study of the live,attenuated,tetravalent dengue vaccine (CYD-TDV) in Thailand
    Kriengsak Limkittikul
    Weerawan Hattasingh
    Danaya Chansinghakul
    Arunee Sabchareon
    Wut Dulyachai
    Carina Frago
    T Anh Wartel
    Edith Langevin
    Sophia Gailhardou
    Alain Bouckenooghe
    Asian Pacific Journal of Tropical Medicine, 2019, (09) : 396 - 403
  • [9] Replication and Excretion of the Live Attenuated Tetravalent Dengue Vaccine CYD-TDV in a Flavivirus-Naive Adult Population: Assessment of Vaccine Viremia and Virus Shedding
    Torresi, Joseph
    Richmond, Peter C.
    Heron, Leon G.
    Qiao, Ming
    Marjason, Joanne
    Starr-Spires, Linda
    van der Vliet, Diane
    Jin, Jing
    Wartel, T. Anh
    Bouckenooghe, Alain
    JOURNAL OF INFECTIOUS DISEASES, 2017, 216 (07) : 834 - 841
  • [10] Long-term safety follow-up of children from a randomized-controlled phase II b proof-of-concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD-TDV) in Thailand
    Limkittikul, Kriengsak
    Hattasingh, Weerawan
    Chansinghakul, Danaya
    Sabchareon, Arunee
    Dulyachai, Wut
    Frago, Carina
    Wartel, T. Anh
    Langevin, Edith
    Gailhardou, Sophia
    Bouckenooghe, Alain
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2019, 12 (09) : 396 - 403
12345